CClinicalTrials.gg
Not yet recruitingNCT06004323Updated Aug 22, 2023

Digital Health Literacy on COVID-19 for All: Co-creation and Evaluation of Interventions for Ethnic Minorities and Chinese People With Chronic Illnesses in Hong Kong

An interventional study of Digital health literacy intervention in Digital Health Literacy and COVID-19, sponsored by The Hong Kong Polytechnic University. Not yet recruiting. Open to participants aged Up to 100 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-08-22.

Sponsored by The Hong Kong Polytechnic University · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Primary completion was expected by Dec 2024, 1 year 9 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
528
Allocation
Randomized
Ages
Up to 100 Years
Sex
All
01

Study summary

During the pandemic, people are anxious for information, and electronic platform serves the purpose of having first-hand health information and spreading it to massive population within a short time. However, the source and credibility of the influx of online information are hard to be verified. Digital health literacy (DHL) is the capacity to access, understand, evaluate, and apply health information from electronic sources, which is an important attribute that everyone should possess. Recent studies from our group in Hong Kong have shown that, during the COVID-19 pandemic, DHL is an issue facing people of all ages, especially ethnic minorities (EMs), people with chronic illnesses (PWCI), and professional and lay caregivers (CGs). Considering that, the present research project aims to co-create DHL interventions with these three groups of people to meet their specific needs in DHL, in addition, to assess the efficacy of the DHL interventions on eHealth literacy, vaccine literacy, and actions taken for COVID-19 prevention. The present research is a 4-year project, involving three phases. Phase 1 involves focus group interviews and cognitive interviews with the three groups of people for developing interventions and evaluating the proposed interventions. Phase 2 involves individual interviews with the three groups of people for testing the feasibility and acceptability of the interventions. Phase 3 involves a 6-month longitudinal quantitative research, testing for the efficacy of the interventions in three dimensions: literacy, attitude, and behavior. Participants from the three groups will be invited to join virtual or face-to-face training, watch short videos on social media, participate in virtual bi-weekly group discussion, and fill in questionnaires for five times during the course of the study. This co-creation of new knowledge by stakeholders and researchers is expected to increase the uptake of the research outcomes and adoption of the DHL interventions.

02

Conditions studied

  • Digital Health Literacy
  • COVID-19

Keywords

  • Digital health literacy
  • COVID-19
  • Ethnic minorities
  • Chinese people with chronic illnesses
03

In context

COVID-19

7,640 studies on the registry are indexed under COVID-19; 488 are open to participants now.

This study's planned enrollment of 528 is above the median of 100 across 4,099 interventional studies indexed under COVID-19.

Browse COVID-19 studies →

Lead sponsor

The Hong Kong Polytechnic University is the lead sponsor of 659 studies on the registry; 250 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 100 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • ethnic minorities (EMs), people with chronic illnesses (PWCI), and caregivers (CGs)
  • able to use a computer, smartphone, or laptop to access the Internet at home

Exclusion criteria

Exclusion Criteria:

  • diagnosis of an acute psychotic disease or life-limiting condition; having a visual, auditory, or fine motor disorder.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
528 participants (estimated)

Study arms

  • Experimental
    Digital health literacy intervention

    The interventions will be developed based on the Best Practices for Digital Health Literacy, WHO health literacy toolkits and the findings of the interviews. The content to be covered in the intervention will include news about vaccines; alerts about COVID-19 preventive measures; guidelines on social distancing, COVID-19 screening test arrangements, vaccination and compulsory quarantines; COVID-19-related law enforcement; and self-monitoring of COVID-19 symptoms

    Behavioral: Digital health literacy intervention

  • No intervention
    Control

    No intervention will be provided to the control group

Interventions

  • BehavioralDigital health literacy intervention

    Participants from the intervention group will be invited to join virtual or face-to-face training, watch short videos on social media, participate in virtual bi-weekly group discussion, and fill in questionnaires for five times during the course of the study

06

What researchers measure

Primary outcomes

  1. eHealth Literacy Efficacy

    Measured by the eHealth Literacy scale (eHEAL), an 8-item self-reported efficacy scale scored on a 5-point Likert scale

    Time frame: baseline, 8-week post intervention, 4-week post follow-up, 8-week follow up, and 12 week follow up

Secondary outcomes

  1. Digital Health Literacy

    Measured by Digital Health Literacy Instrument

    Time frame: baseline, 8-week post intervention, 4-week post follow-up, 8-week follow up, and 12 week follow up

  2. Vaccine literacy

    knowledge about and intention to receive the COVID-19 vaccine

    Time frame: baseline, 8-week post intervention, 4-week post follow-up, 8-week follow up, and 12 week follow up

  3. Knowledge, attitudes, and practices towards COVID-19

    Assess knowledge, attitudes, and practices towards COVID-19

    Time frame: baseline, 8-week post intervention, 4-week post follow-up, 8-week follow up, and 12 week follow up

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No — Data can be obtained from principal investigator.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 22, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06004323
Lead sponsor
The Hong Kong Polytechnic University
Responsible party
Dr Angela Leung (Professor, The Hong Kong Polytechnic University) — Principal investigator
First posted
Aug 22, 2023
Start date
Sep 1, 2023 (estimated)
Primary completion
Dec 31, 2024 (estimated)
Completion
Dec 31, 2024 (estimated)
Last update
Aug 22, 2023

Study contacts

Angela Leung, PhD
Contact
angela.ym.leung@polyu.edu.hk
27665587

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion